You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Low-Dose Mesylate salt of Paroxetine (LDMP)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in Canada, United States (Dasatinib, Imatinib Mesylate, Laboratory

Active, not recruiting
Has Results
  • Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Burbank, California
  • +340 more
Jan 28, 2023

Salt-Sensitivity of Blood Pressure Trial (Furosemide (Diuretic), Hypertonic Saline Infusion)

Not yet recruiting
  • Salt-Sensitivity of Blood Pressure
  • Furosemide (Diuretic)
  • Hypertonic Saline Infusion
  • (no location specified)
Oct 17, 2023

Anxiety Disorders Trial (Paroxetine)

Not yet recruiting
  • Anxiety Disorders
  • (no location specified)
Sep 26, 2023

Multiple Myeloma Trial in Houston (Belumosudil mesylate)

Not yet recruiting
  • Multiple Myeloma
  • Belumosudil mesylate
  • Houston, Texas
    M D Anderson Cancer Center
Oct 31, 2023

Chronic Hepatitis B Trial in Seoul (Standard of care)

Active, not recruiting
  • Chronic Hepatitis B
  • Standard of care
  • Seoul, Korea, Republic of
  • +3 more
Mar 29, 2023

Salt; Excess, Hypertension Trial in Auburn (No Salt, No ß-OHB, High Salt, No ß-OHB, High Salt, High ß-OHB)

Not yet recruiting
  • Salt; Excess
  • Hypertension
  • No Salt, No β-OHB
  • +2 more
  • Auburn, Alabama
    Auburn University
Jan 31, 2023

Rheumatoid Arthritis Trial in Shibin Al Kawm (Paroxetine, Placebo)

Recruiting
  • Rheumatoid Arthritis
  • Shibīn Al Kawm, Menoufia, Egypt
    Faculty of Pharmacy
Jan 16, 2023

Heart Failure, Systolic, Sodium Imbalance, Food Selection Trial in Venlo (Low sodium bread, Placebo)

Completed
  • Heart Failure, Systolic
  • +2 more
  • Low sodium bread
  • Placebo
  • Venlo, Limburg, Netherlands
    ViecuriMC
Nov 22, 2022

Healthy Trial in Saint-Herblain (5-MTHF glucosamine salt, 5-MTHF calcium salt 1, 5-MTHF calcium salt 2)

Recruiting
  • Healthy
  • 5-MTHF glucosamine salt
  • +2 more
  • Saint-Herblain, France
    Biofortis
Jan 31, 2023

Healthy Trial in Soeul (DA-8010 5mg, Paroxetine 20mg, Mirabegron 50mg)

Not yet recruiting
  • Healthy
  • DA-8010 5mg
  • +2 more
  • Soeul, Korea, Republic of
    Seoul National University Hospital
Aug 7, 2023

Diffuse Large B Cell Lymphoma,DLBCL Trial in Chengdu (PM 8.4 mg/m2, PM 11.2 mg/m2)

Recruiting
  • Diffuse Large B Cell Lymphoma，DLBCL
  • PM 8.4 mg/m2
  • PM 11.2 mg/m2
  • Chengdu, Sichuan, China
    West China Hospital Sichuan University
Jan 15, 2023

CML Trial in Tempe (Imatinib Mesylate, IkT-001Pro)

Recruiting
  • CML
  • Tempe, Arizona
    Celerion
Nov 21, 2022

Hypertension Trial in Athens (Salt Restriction Group (SRG), DASH Diet combined with salt restriction Group (DDG), Mediterranean

Completed
  • Hypertension
  • Salt Restriction Group (SRG)
  • +2 more
  • Athens, Greece
    Hypertension Unit, First Cardiology Clinic, Hippocration General
Jan 9, 2023

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8

Terminated
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Bintrafusp Alfa
  • Eribulin Mesylate
  • Houston, Texas
  • +1 more
Oct 27, 2022

Neural Tube Defects, Folic Acid Deficiency, Fortification Trial in Birmingham (Salt with folic acid and iodine)

Active, not recruiting
  • Neural Tube Defects
  • +2 more
  • Salt with folic acid and iodine
  • Birmingham, Alabama
    University of Alabama at Birmingham
Jul 6, 2023

Gaucher's Disease Type I Trial (Genz-112638, [14C]-Genz-112638)

Completed
  • Gaucher's Disease Type I
  • (no location specified)
Nov 16, 2023

Blood Pressure Trial (Reduced-sodium potassium-enriched salt)

Not yet recruiting
  • Blood Pressure
  • Reduced-sodium potassium-enriched salt
  • (no location specified)
Jun 12, 2023

Advanced Malignant Solid Tumor, C-KIT Tyrosine Kinase Protein Overexpression, Clinical Stage IV Cutaneous Melanoma AJCC v8 Trial

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +8 more
  • Imatinib Mesylate
  • Ipilimumab
  • Houston, Texas
    M D Anderson Cancer Center
Aug 1, 2022

Blood Pressure Trial (Main study intervention-Salt substitute, Main study control-Usual salt, Ancillary study intervention-Meal

Not yet recruiting
  • Blood Pressure
  • Main study intervention-Salt substitute
  • +3 more
  • (no location specified)
Oct 19, 2023

Postural Orthostatic Tachycardia Syndrome Trial (Sodium Chloride Capsules, Microcystalline Cellulose Capsules)

Not yet recruiting
  • Postural Orthostatic Tachycardia Syndrome
  • Sodium Chloride Capsules
  • Microcystalline Cellulose Capsules
  • (no location specified)
Jun 28, 2023

Liposarcoma, Malignant Abdominal Tumor, Malignant Retroperitoneal Tumor Trial in Portland (drug, radiation, other, procedure)

Recruiting
  • Liposarcoma
  • +5 more
  • Eribulin Mesylate
  • +5 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Oct 17, 2022

Dialysis; Complications, Bleeding Trial in Wonju (Nafamostat Mesylate)

Recruiting
  • Dialysis; Complications
  • Bleeding
  • Nafamostat Mesylate
  • Wonju, Kangwondo, Korea, Republic of
    Yonsei Unviersity Wonju College of Medicin
May 22, 2023

Hypercapnia, Ventilatory Depression Trial in West Bend (Placebo and Oxycodone, Paroxetine and Oxycodone, Escitalopram and

Not yet recruiting
  • Hypercapnia
  • Ventilatory Depression
  • Placebo and Oxycodone
  • +2 more
  • West Bend, Wisconsin
    Spaulding Clinical Research
Jul 20, 2022

CKD Progression, Blood Pressure, Proteinuria Trial in Bangkok (Low salt diet)

Not yet recruiting
  • CKD Progression
  • +2 more
  • Low salt diet
  • Bangkok, Thailand
    Faculty of Medicine,Vajira Hospital,Navamindradhiraj University
Feb 7, 2023

Diabetes Trial in Boston (Para-aminohippuric Acid, Angiotensin II, Norepinephrine)

Terminated
  • Diabetes Mellitus
  • Para-aminohippuric Acid
  • +2 more
  • Boston, Massachusetts
    Brigham and Women's Hospital- 221 Longwood Avenue
Nov 7, 2022